Food fix

Houston startup claims HEB award and heads for shelves

Grand prize winner, Traci Johannson, 3 Sons Foods; Jody Hall, H-E-B; George Johannson; Winell Herron, H-E-B; Luke and Ayden Johannson; James Harris, H-E-B. Photo courtesy of H-E-B

Five homegrown Texas businesses are enjoying Lone Star State-sized bragging rights after a big win on August 8. The entrepreneurs are the collective winners of H-E-B's sixth-annual Primo Picks Quest for Texas Bestcontest, which recognizes the most innovative products. Collectively, the winners earn $80,000 in prizes, and, just as important, coveted shelf space in H-E-Bs across the state.

A Houston family leads the way, joining winners from Austin; San Antonio; Woodway; and Atlanta, Texas. Houston's 3 Sons Foods won a grand prize of $25,000 and featured placement as a Texas Primo Pick for Diablo Verde Sauce, a creamy cilantro offering. The company is owned by and operated by Traci Johannson and her three young sons: George (11), Luke (14), and Ayden (16). A portion of Diablo Verde sales goes to the International Rhino Foundation to help stop the illegal poaching of rhinos, according to a release.

First place honors — and a $20,000 prize — go to Austin's Courtney Ray Goodson for her Uncle Ray's Peanut Brittle. Inspired by her great uncle Ray's 35-year-old recipe, Goodson's offerings include Bacon Pecan, Butternut, Pecan, and classic Peanut Brittle.

Hailing from Woodway, Texas, Derek Newball landed second place and $15,000 for his EVOKE collagen drink. Capitalizing on the collagen drink trend, Newball's coconut-based products are meant to benefit skin, hair, joints, and bones, and come in coconut, mandarin coconut, and pineapple coconut flavors.

To the Moon Family Foods, based in Atlanta, Texas, tied for third place (a $10,000 prize) with its To the Moon Family Foods Nutty-Carrot Spread. Creators Kay Lynn York and Joan Reece combine carrots, pecans, and "mouthwatering" spices for a spread to be used on sandwiches; meats; or even rolled in balls, coated, and fried.

Tying with To the Moon at third place (and a $10,000 prize) is San Antonio's Grain4Grain Low-Carb Flour and Mix. Owners Yoni Medhin and Matt Mechtly recycle spent grains from local microbreweries to make a low-carb, high-protein, high-fiber flour. For every pound of flour sold, Grain4Grain donates a pound to those in need.

The 2019 Quest for Texas Best competition drew more than 800 entries from nearly 140 cities and towns across the state after a call for entries in February of this year. Through two qualifying rounds, submissions were judged on taste and flavor, customer appeal, value, uniqueness, market potential, and differentiation from current products at most H-E-B stores.

"Each of these 20 competitors displayed unprecedented creativity, style, and commitment to providing outstanding, unique products for our consideration," said James Harris, director of diversity & inclusion and supplier diversity at H-E-B, in a statement. "In fact, the entries were so good that we ended up with five winners this year. We are delighted to share that diversity and ingenuity with our customers across the state."

------

This story originally appeared on CultureMap.

Trending News

Building Houston

 
 

BiVACOR has received fresh funding from its investors to further develop its artificial heart. Photo courtesy of BiVACOR

A Houston medical device company that is developing an artificial heart announced it has received investment funding to the tune of $18 million.

BiVACOR's investment round was led by Boston-based Cormorant Asset Management and Australia's OneVentures's Healthcare Fund III. According to the company, the funding will be deployed to continue research and development, hiring executives, and support the path to first in human trials.

“We are extremely grateful for the ongoing support from our core investors," says Thomas Vassiliades, who was named CEO of BiVACOR last year, in a news release. "This additional commitment further validates our technology and the need for improved options to treat end-stage biventricular heart failure.

“With this financing, we will be able to double the size of our organization and add key positions from the C-suite to research and development. We are well positioned to advance our preclinical activities and aim to conduct our First in Human early feasibility study planned for the end of the year,” he continues.

Billed as the first long-term treatment for patients with severe biventricular heart failure, the BiVACOR Total Artificial Heart is an implantable artificial heart that utilizes rotary blood pump technology. This technology includes magnetic levitation and is a "durable, reliable, and biocompatible heart replacement," per the company's release. It's about the size of a fist and can be used in a wide range of patients including some children and women and up to adult males.

“Under the leadership of its expert management team, the company has developed a credible strategy for growth as they march toward first in human studies,” says Jeannie Joughin, board chair and principal at One Ventures, in the release. “There is a huge gap in care for patients waiting for a heart transplant, and we are confident that BiVACOR will continue to execute its strategy to swiftly get the Total Artificial Heart into the patients who need it most.”

The company raised its $22 million series B round in early 2021, which was also led by Cormorant Asset Management and OneVentures. To date, BiVACOR has raised $60 million.

“BiVACOR continues to execute on its strategy, and there was no question that we would jump in to lead this funding,” says Bihua Chen, CEO and founder of Cormorant Asset Management. “We are impressed by BiVACOR’s world-class team and continued dedication to push the technology in the clinic. We’re excited to support their growth and vision to transform the treatment of biventricular heart failure with the world’s first fully MAGLEV total artificial heart.”

Founded in 2008, BiVACOR maintains offices in Cerritos, California, and Brisbane, Australia. The company is affiliated with Houston's Texas Heart Institute, where the world's first artificial heart was implanted. BiVACOR's headquarters is at the Texas Medical Center complex.

Trending News